Why and how validate criteria by manual smear review to improve laboratory productivity?  by Grotto, Helena Zerlotti Wolf
LW
r
D
I
p
H
l
s
e
b
r
h
i
r
n
s
o
o
o
o
n
u
m
f
e
m
a
p
a
f
e
s
w
t
e
e
t
s
grev bras hematol hemoter. 2 0 1 5;3  7(1):67–68
Revista Brasileira de Hematologia e Hemoterapia
Brazilian Journal of Hematology and Hemotherapy
www.rbhh.org
etter to the Editorhy  and  how  validate  criteria  by manual  smear
eview to  improve  laboratory  productivity?ear Editor,
 read the article “Are the review criteria for automated com-
lete blood counts of the International Society of Laboratory
ematology suitable for all hematology laboratories?”, pub-
ished in RBHH 2014;36(2);219–225,1 and I would like to make
ome comments about it.
The purpose of the study is remarkable and it is known that
ach Laboratory has to deﬁne their own criteria for reviewing
lood smears. Several studies have reported different expe-
iences when manual methods were replaced by automated
ematology systems, all of which described improvements
n quality and precision, in addition to faster reportable
esults.2–4 Comar et al. applied the review criteria of the Inter-
ational Society for Laboratory Hematology in their study with
ome adaptations according to local requirements. A total
f 1977 whole blood samples were analyzed on two pieces
f equipment and 100 leukocytes were counted by a single
bserver. Among other results, the authors reported high rates
f microscopy reviews and an unacceptable percentage of false
egative results (>5%).
Some considerations should be mentioned about this eval-
ation. First, and most important in my view, is related to
icroscopic analysis. According to the National Committee
or Clinical Laboratory Standards (NCCLS) document ‘Refer-
nce Leukocyte (WBC) Differential Count, H20-A2’5 some rules
ust be followed in order to obtain a reliable analysis, such
s: (i) three blood ﬁlms from each specimen should be pre-
ared (two are used for the procedure and the third is kept as
 spare); (ii) a larger number of blood ﬁlms must be prepared
or leukopenic samples; (iii) 200 WBC  should be counted on
ach slide; and (iv) at least two examiners must be able to clas-
ify all normal and abnormal cells. These recommendations
ere not followed in the study, which may explain, according
o the authors, “the inadequate performance of both pieces of
quipment”. Other studies, using the NCCLS Document as an
6valuation protocol, showed different results. Rusicka et al.
ested the efﬁciency of ﬂagging using the XE-2100 device and
howed that the rate of false negative results of the immature
ranulocyte category was only 1% and the efﬁciency rate ofmyeloid precursor cell detection was 84%. Regarding the false
negative results for blasts, the rate was 1% (5 samples), all of
them showing leukocyte counts <2.5 × 109/L, and four of them
were ﬂagged by the atypical lymph ﬂag or IG ﬂag. This means
that, although the blast cell was not detected, the blood cell
smear should be examined due to additional ﬂags. Another
study was published by Stamminger et al.7 where 800 cells
were analyzed per sample. The authors considered the Left
Shift to be positive if band cells were >0.9 × 109/L or 6% and/or
a neutrophil proportion >80%. The efﬁciency of the Left Shift
ﬂag was 0.86 (sensitivity 0.53 and speciﬁcity 0.92). When the
combination Left Shift plus neutrophilia was  applied, there
was a signiﬁcant increase in the efﬁciency (0.92), sensitivity
(0.83) and speciﬁcity (0.92). Considering the variations in mor-
phological deﬁnition of the band cell, the count of this cell in
the routine laboratory is apparently unreliable.
In summary, the progress of hematology automation and
the achieved good levels of precision and the accuracy in cell
counting are incontestable. The examination and identiﬁca-
tion of thousands of cells in each sample, the improvement in
technologies and the incorporation of new parameters provide
reliable and applicable information for diagnosis in several
clinical conditions. Automation will most likely never totally
replace the microscopic review of blood cells. The examina-
tion of red cell morphology is crucial for the diagnosis of
anemia, and automation does not provide all the information
that is potentially important to the physician.8 The purpose
of automation is to provide faster reportable results, to reduce
the technologist hands-on time, in addition to providing high
quality and precision. Each laboratory must deﬁne the best
criteria to achieve their performance goals. Several tools and
guidelines are available to analyze the performance of equip-
ment, and to deﬁne the best rules for speciﬁc needs.Conﬂicts  of  interest
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